Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to Oryzon Genomics

Shares of Spanish biotech company Oryzon Genomics plummeted more than 23 percent after Swiss drug giant Roche ended a three-year-old developmental deal for the company’s leukemia and cancer treatments. 

Read More »

Ablynx signs Sanofi deal potentially worth up to $2.8 billion

French drugmaker Sanofi boosted its early-stage pipeline in immunology by signing a deal with Ablynx that could earn the Belgian biotech firm as much as 2.4 billion euros ($2.8 billion).

Read More »

Long work hours tied to irregular heart rhythm

People who typically work much more than 35 to 40 hours a week may be at heightened risk of developing atrial fibrillation, an irregular rapid heartbeat that can lead to strokes, heart failure and chronic fatigue, a recent study suggests.

Read More »

Belgian doctors pin hope on large brain collection to treat diseases

A psychiatric hospital in Belgium is home to one of the world’s largest collections of human brains, which researchers say could hold the key to developing new treatments for diseases such as psychosis, schizophrenia and severe depression.

Read More »

EU watchdog concerned drug agency EMA may be too close to companies

The European Medicines Agency (EMA), eager to accelerate access to promising new drugs, may be getting too cozy with the pharmaceutical companies it regulates.

Read More »

Siemens Breaks Ground on $300 Million Expansion in Walpole, Mass., Plans for 700 New Jobs

Siemens Healthineers broke ground on a $300 million expansion at its Massachusetts-based laboratory diagnostics, manufacturing and research and development facility. 

Read More »

Novartis Boss Updates Q2 2017 Financials, Reaffirms M&A Strategy

Novartis CEO Joe Jiminez spoke with investors and analysts regarding the company’s half-year financials.

Read More »

Senate Republicans reluctantly consider bipartisan healthcare talks

As their seven-year effort to repeal and replace Obamacare derailed in the U.S. Senate, Republicans faced the prospect of doing the once unthinkable: working with Democrats to make fixes to former President Barack Obama’s 2010 healthcare law.

Read More »

FDA Green Lights Gilead’s Vosevi; Black-Box Warning Attached

The FDA approved Gilead Sciences’ Vosevi, an oral medicine for the re-treatment of chronic HCV.

Read More »

Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials

Vertex Pharmaceuticals announced positive efficacy data from its Phase I and Phase II studies of three different triple combination regimens for cystic fibrosis patients,

Read More »

Nektar Announces Topline Data from HAP Study for NKTR-181

NKTR-181 shows significantly less abuse potential compared to oxycodone.

Read More »

Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug

The FDA approved Puma Biotechnology’s breast cancer drug Nerlynx (neratinib).

Read More »

Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA

The FDA is tackling a new way to recruit top talent — talent that will fill a “substantial” number of vacant position.

Read More »

Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston

July 18, 2017 By Mark Terry, Breaking News Staff Chicago, Ill. – Takeda Pharmaceuticals (TKPYY) is shifting hundreds of executives from the Chicago area to relocate to Boston. It is also cutting hundreds of field sales positions throughout the U.S.   In March, the company indicated it was making job cuts in the Cambridge, […]

Read More »

Dengue kills 21 in Indian tourist hotspot, crisis looms

THIRUVANANTHAPURAM, India (Reuters) – A dengue outbreak has killed at least 21 people in India’s southern state of Kerala in the past three weeks, a government official said, adding that there was a shortage of medicines and health workers to tackle the crisis in the tourist hotspot. The mosquito-borne dengue virus, which causes flu-like symptoms […]

Read More »

More hospital closings in rural America add risk for pregnant women

By Jilian Mincer Bay Minette, Alabama (Reuters) – Dr. Nicole Arthur, a family practice physician, was trained to avoid Cesarean deliveries in child-birth, unless medically necessary, because surgery increases risks and recovery time. But she has adjusted her approach since arriving last year at the 70-bed North Baldwin Infirmary in rural, southern Alabama. Low patient […]

Read More »

U.S. Senate Republicans set repeal vote as healthcare overhaul sinks

  By Susan Cornwell   WASHINGTON (Reuters) – U.S. Senate Republicans will vote on a straight repeal of Obamacare after efforts to overhaul the law collapsed, rattling financial markets on Tuesday and clouding the path forward for President Donald Trump’s other domestic policy goals. After two Republicans said they would not back the latest Obamacare […]

Read More »

UDG Healthcare announces acquisition of Cambridge BioMarketing for up to $35M

UDG Healthcare plc announced the acquisition of Cambridge BioMarketing LLC, a U.S.-based healthcare communications business, for a total consideration of up to $35 million.

Read More »

Artificial sweeteners may not be risk free

People hoping to lose a few pounds by substituting artificial sweeteners for regular sugar may end up disappointed, suggests a fresh look at past research.

Read More »

Fingerpaint Taps Accomplished Duo to Lead Creative Team

Fingerpaint, a full-service marketing agency with offices in Arizona, Pennsylvania, New York and Ohio, named a longtime creative duo as the new leaders of the agency’s creative team. Katie Beller and Andy Spitzer will be based in the agency’s headquarters in Saratoga Springs, New York.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom